156 related articles for article (PubMed ID: 35372462)
1. Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis.
Liang X; Wang Y; Pei L; Tan X; Dong C
Front Surg; 2022; 9():856446. PubMed ID: 35372462
[TBL] [Abstract][Full Text] [Related]
2. Identification of ARHGEF38, NETO2, GOLM1, and SAPCD2 Associated With Prostate Cancer Progression by Bioinformatic Analysis and Experimental Validation.
Sun Z; Mao Y; Zhang X; Lu S; Wang H; Zhang C; Xiao C; Cao Y; Qing Y; Wang Y; Li K
Front Cell Dev Biol; 2021; 9():718638. PubMed ID: 34540835
[TBL] [Abstract][Full Text] [Related]
3. Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer.
Zhang Q; Zhang P; Zhao Z; Wang J; Zhang H
PeerJ; 2023; 11():e15013. PubMed ID: 37070095
[TBL] [Abstract][Full Text] [Related]
4. Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation.
Quan Y; Zhang X; Wang M; Ping H
Front Oncol; 2022; 12():981226. PubMed ID: 36237332
[TBL] [Abstract][Full Text] [Related]
5. EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients.
Liao Y; Wu M; Jia Y; Mou R; Li X
Front Cell Dev Biol; 2022; 10():843604. PubMed ID: 35517503
[No Abstract] [Full Text] [Related]
6. Identification of Potential Key Genes for Pathogenesis and Prognosis in Prostate Cancer by Integrated Analysis of Gene Expression Profiles and the Cancer Genome Atlas.
Liu S; Wang W; Zhao Y; Liang K; Huang Y
Front Oncol; 2020; 10():809. PubMed ID: 32547947
[No Abstract] [Full Text] [Related]
7. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
[No Abstract] [Full Text] [Related]
8. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway.
Zhang X; Tian C; Cheng J; Mao W; Li M; Chen M
Exp Ther Med; 2022 Sep; 24(3):563. PubMed ID: 36034756
[TBL] [Abstract][Full Text] [Related]
9. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
10. The Identification of Key Gene Expression Signature in Prostate Cancer.
Huang Y; Cao Q; Song Z; Ruan H; Wang K; Chen K; Zhang X
Crit Rev Eukaryot Gene Expr; 2020; 30(2):153-168. PubMed ID: 32558494
[TBL] [Abstract][Full Text] [Related]
11. Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining.
Liu K; Chen Y; Feng P; Wang Y; Sun M; Song T; Tan J; Li C; Liu S; Kong Q; Zhang J
Front Genet; 2022; 13():854531. PubMed ID: 35360870
[No Abstract] [Full Text] [Related]
12. Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis.
Li J; Chen S; Liao Y; Wang H; Zhou D; Zhang B
Front Oncol; 2022; 12():925743. PubMed ID: 35875097
[TBL] [Abstract][Full Text] [Related]
13. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
14. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
15. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
16. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
17. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
Yang Y; Jia B; Zhao X; Wang Y; Ye W
J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
[No Abstract] [Full Text] [Related]
19. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
20. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
[Next] [New Search]